Edition:
India

MyoKardia Inc (MYOK.OQ)

MYOK.OQ on NASDAQ Stock Exchange Global Select Market

58.70USD
10:40pm IST
Change (% chg)

$0.45 (+0.77%)
Prev Close
$58.25
Open
$58.75
Day's High
$59.40
Day's Low
$57.45
Volume
37,252
Avg. Vol
114,494
52-wk High
$59.40
52-wk Low
$10.85

Chart for

About

MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. The Company is engaged in the business of developing and commercializi... (more)

Overall

Beta: --
Market Cap(Mil.): $1,434.94
Shares Outstanding(Mil.): 34.96
Dividend: --
Yield (%): --

Financials

BRIEF-Myokardia Begins Patient Dosing In Phase 1B Clinical Study Of Myk-491

* MYOKARDIA BEGINS PATIENT DOSING IN PHASE 1B CLINICAL STUDY OF MYK-491 IN DILATED CARDIOMYOPATHY PATIENTS

14 Feb 2018

BRIEF-MyoKardia Inc reports Q3 loss per share $0.42

* MyoKardia Inc reports third quarter 2017 financial results and operational progress

03 Nov 2017

BRIEF-MyoKardia expects to initiate next trial of MYK-491 in DCM patients by year-end

* MyoKardia Inc - ‍next trial of MYK-491 in DCM patients expected to initiate by year-end​

27 Sep 2017

Earnings vs. Estimates